Hyperinsulinemia and corruption of CEACAM1-mediated repression on hepatic fatty acid synthase (FASN) activity in hyperinsulinemia further support hepatic steatosis and SREBP1c-mediated lipogenesis and are accompanied by a reduction in hepatic β-oxidation [115,127,130]. The gene discussed is CEACAM1; the disease is fatty liver disease.